Scientists at UCLA have created a new kind of immune cell therapy that could change how advanced kidney cancer is treated. Unlike most current therapies that need to be custom-made for each patient, this one is ready to use right out of the lab. Called AlloCAR70 NKT, it’s built from stem cells and trained to hunt down a protein named CD70, which is often found on kidney cancer cells. Traditional CAR T therapies have had a tough time fighting solid tumors because they’re complex to make and don’t